Event

PSI Journal Club: Survival Analysis

Overview

Our next journal club features two papers on the topic of Survival Analysis. The webinar will be held on the 24th March 2021 from 4-5pm GMT. 
Please click here to view the flyer.

Registration

REGISTER HERE: https://attendee.gotowebinar.com/register/666145030521313291

The journal club gives a forum to participate and listen to discussion on different topics.
Who is this event intended for? Anyone with an interest in Survival Analysis including discussions on sample size calculations, non-parametric survival comparisons and methods allowing for delayed treatment effects.
What is the benefit of attending? People should attend to learn more about the different techniques and applications of survival analysis methods for delayed treatment effects and non-proportional hazards.

Please join us to hear Dominic Magirr (Novartis) and Chang Yu (Vanderbilt University) present their recent work. The webinar will be chaired by Jennifer Rogers (PHASTAR).

Presenters

Dominic Magirr (Novartis):- Non‐proportional hazards in immuno‐oncology: Is an old perspective needed?
Authors: Dominic Magirr
Pharmaceutical Statistics. 20 20;1-16

Chang Yu (Vanderbilt University):- A weighted log‐rank test and associated effect estimator for cancer trials with delayed treatment effect
Authors: Chang Yu, Xiang Huang, Hui Nian and Philip He Pharmaceutical Statistics. 20 21;1– 23

For each of these published papers there will be a 20 minute presentation by author followed by a 10 minute discussion.
Papers will be made available to view prior to the meeting and presentation slides will be available a week before the JC. Journal subscribers can access papers at any time.  Audio recordings will be available shortly after the JC to download from the PSI website.
The meetings are open to both PSI and non-PSI members. 

Upcoming Events

PSI VisSIG Wonderful Wednesday Webinar Series

This is a good opportunity to develop your knowledge by thinking through a practical example, practicing how to apply graphics principles, and developing your coding skills.

PSI VIS SIG Webinar: Collaborative & Exploratory Data Analysis

In this talk, you will learn how to quickly explore your data in the web browser and how to create, collaborate and share interactive visualisations with others.

PSI Pre-Clinical SIG Webinar: Assay Qualification by Linear Mixed Model: Confidence, Prediction & Tolerance Intervals

Dr Francq will discuss the need for analytical methods to deliver unbiased and precise results and talk in detail on confidence, prediction and tolerance intervals work in linear mixed models and the interpretation of statistical results. This will be followed by Q&A.

PSI Training Course: An Interactive Introduction to Agile Ways of Working

During this session you will explore how we best execute change within our roles, build your practical understanding of agile tools and techniques, and inspire you to experiment with the new ways of working to deliver your goals.

PSI EIWG Webinar: Impact of estimands

To understand how the estimand framework changed the development of clinical trials.

PSI Training Course: Hybrid Frequentist / Bayesian Power and Bayesian Power in Planning Clinical Trials

Aimed at Statisticians working on the design of Clinical Trials, participants will learn how to use Expected Power, Average Power, Predicted Power, Probability of Success and Assurance, and Bayesian Power when planning clinical trials.

Latest Jobs

Apprentice Biostatistician

The Apprentice Biostatistician splits their time between working for Parexel and performing studies with a university to obtain a MSc in Statistics over a period of three years.

Biostatistician / Statistical Programmer

We are actively looking to expand our team in Wokingham with a permanent position for a Biostatistician / Statistical Programmer.

Principal Statistician combining biomarker analysis with clinical data

We are looking for a Principal Statistician to be part of exciting work combing clinical trial data and biomarker data to support the future development of molecules within the therapeutic areas of obesity and NASH.

Statistical experts for cardio-renal outcome trials

Biostatistics GLP-1 & CV 1 is seeking statisticians at Specialist and Principal level to be part of the biostatistics team responsible for Novo Nordisk’s large cardiovascular outcomes trials.

Statistical experts for drug development

The position will be made to match the seniority of the candidate and for the right candidate we offer the opportunity to work mostly homebased from European locations.